Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Sznol

Showing results (1-10 of 188) with videos related to

Pageof 19
Sort By:
Current Oncology Reports|August 15, 2009
Betting on immunotherapy for melanomaMario Sznol
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Challenges in Conducting Clinical Research on Patients With Advanced MelanomaMario Sznol
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic MelanomaMario Sznol
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Revisiting ribonucleotide reductase as a target to enhance radiation and chemotherapy anti-tumor activityMario Sznol
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2021
TIL in Melanoma-Similar Approaches, Different Results, Unanswered QuestionsMario Sznol
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular markers of response to treatment for melanomaMario Sznol
Seminars in Oncology|April 10, 2012
Advances in the treatment of metastatic melanoma: new immunomodulatory agentsMario Sznol
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Developing enabling technologies for the success of cancer immunotherapyMario Sznol
Cancer Journal (Sudbury, Mass.)|August 8, 2014
Blockade of the B7-H1/PD-1 pathway as a basis for combination anticancer therapyMario Sznol
Oncology (Williston Park, N.Y.)|November 27, 2012
Relative roles of targeted therapies and immunotherapies in melanomaMario Sznol
Pageof 19

Showing results (1-10 of 188) with videos related to

Sort By:
Pageof 19
Current Oncology Reports|August 15, 2009
Betting on immunotherapy for melanomaMario Sznol
Cancer Journal (Sudbury, Mass.)|January 24, 2017
Challenges in Conducting Clinical Research on Patients With Advanced MelanomaMario Sznol
Clinical Advances in Hematology & Oncology : H&O|September 9, 2020
Reversing Resistance to Checkpoint Inhibitors and Targeted Therapy in Metastatic MelanomaMario Sznol
Cancer Journal (Sudbury, Mass.)|September 12, 2003
Revisiting ribonucleotide reductase as a target to enhance radiation and chemotherapy anti-tumor activityMario Sznol
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 20, 2021
TIL in Melanoma-Similar Approaches, Different Results, Unanswered QuestionsMario Sznol
Cancer Journal (Sudbury, Mass.)|March 24, 2011
Molecular markers of response to treatment for melanomaMario Sznol
Seminars in Oncology|April 10, 2012
Advances in the treatment of metastatic melanoma: new immunomodulatory agentsMario Sznol
Current Opinion in Investigational Drugs (London, England : 2000)|January 15, 2005
Developing enabling technologies for the success of cancer immunotherapyMario Sznol
Cancer Journal (Sudbury, Mass.)|August 8, 2014
Blockade of the B7-H1/PD-1 pathway as a basis for combination anticancer therapyMario Sznol
Oncology (Williston Park, N.Y.)|November 27, 2012
Relative roles of targeted therapies and immunotherapies in melanomaMario Sznol
Pageof 19